129 related articles for article (PubMed ID: 4879902)
1. The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment.
Ragland R; Clark ML; Ray TS; Paredes A; Costiloe JP; Segal B; Wolf S
J Chronic Dis; 1968 Oct; 21(6):445-60. PubMed ID: 4879902
[No Abstract] [Full Text] [Related]
2. A comparison of oxypertine and chlorpromazine in chronic schizophrenia.
Goldberg GJ; Brooke G; Townsend HR; Brahma RK; Hill GB
Acta Psychiatr Scand; 1970; 46(2):126-35. PubMed ID: 4920718
[No Abstract] [Full Text] [Related]
3. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
[No Abstract] [Full Text] [Related]
4. Evaluation of loxapine succinate in chronic schizophrenia.
Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
[No Abstract] [Full Text] [Related]
5. Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.
Clark ML; Ramsey HR; Ragland RE; Rahhal DK; Serafetinides EA; Costiloe JP
Psychopharmacologia; 1970; 18(3):260-70. PubMed ID: 4249733
[No Abstract] [Full Text] [Related]
6. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
Klein DF; Rosen B
Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948
[No Abstract] [Full Text] [Related]
7. High dose trifluoperazine therapy in chronic schizophrenia.
Prien RF; Levine J; Cole JO
Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559
[No Abstract] [Full Text] [Related]
8. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
Prien RF; Levine J; Cole JO
Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
[No Abstract] [Full Text] [Related]
9. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
Kolivakis T; Azim H; Kingstone E
Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
[No Abstract] [Full Text] [Related]
10. Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group.
Arch Gen Psychiatry; 1968 Apr; 18(4):482-95. PubMed ID: 4868797
[No Abstract] [Full Text] [Related]
11. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
[No Abstract] [Full Text] [Related]
12. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
Shopsin B; Pearson E; Gershon S; Collins P
Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
[No Abstract] [Full Text] [Related]
13. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
Serafetinides EA; Collins S; Clark ML
J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
[No Abstract] [Full Text] [Related]
14. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics.
Spohn HE; Lacoursiere RB; Thompson K; Coyne L
Arch Gen Psychiatry; 1977 Jun; 34(6):633-44. PubMed ID: 326215
[TBL] [Abstract][Full Text] [Related]
15. The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.
Spiegel DE; Keith-Spiegel P
J Nerv Ment Dis; 1967 Feb; 144(2):111-6. PubMed ID: 5338760
[No Abstract] [Full Text] [Related]
16. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
Gendron JL; Zimmermann RL; Schiele BC
Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
[No Abstract] [Full Text] [Related]
17. Bioequivalency of generic and brand-named chlorpromazine.
Simpson GM; Varga E; Reiss M; Cooper TB; Bergner PE; Lee JH
Clin Pharmacol Ther; 1974 Jun; 15(6):631-41. PubMed ID: 4210298
[No Abstract] [Full Text] [Related]
18. A comparison of the behavioral effects of periodic administration of chlorpromazine and a "sustained-release" form of chlorpromazine.
Orzack MH; Taylor CL; Kornetsky C
Clin Pharmacol Ther; 1969; 10(2):258-64. PubMed ID: 4887298
[No Abstract] [Full Text] [Related]
19. Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation.
Hamid TA; Wertz WJ
Am J Psychiatry; 1973 Jun; 130(6):689-92. PubMed ID: 4573820
[No Abstract] [Full Text] [Related]
20. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
Platz AR; Klett CJ; Caffey EM
Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
